The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Rigel Pharmaceuticals shares valued at $34,821 were sold by RODRIGUEZ RAUL R on Feb 05 ’24. At $1.14 per share, RODRIGUEZ RAUL R sold 30,545 shares. The insider’s holdings dropped to 2,036,629 shares worth approximately $15.7 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Santos David A sold 8,918 shares, netting a total of over 10,167 in proceeds. Following the sale of shares at $1.14 each, the insider now holds 349,093 shares.
Before that, Schorno Dean L had sold 7,027 shares from its account. In a trade valued at $8,011, the EVP & Chief Financial Officer traded Rigel Pharmaceuticals shares for $1.14 each. Upon closing the transaction, the insider’s holdings decreased to 7,027 shares, worth approximately $3.11 million.
Analysts at Citigroup downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early June. As of June 08, 2022, Piper Sandler has decreased its “an Overweight” rating to a “Neutral” for RIGL. Earlier on June 08, 2022, Cantor Fitzgerald downgraded its rating. Their new recommendation was “a Neutral” for RIGL stock which previously was a “an Overweight”.
Analyzing RIGL Stock Performance
During the last five days, there has been a drop of approximately -2.42%. Over the course of the year, Rigel Pharmaceuticals shares have dropped approximately -46.83%. Shares of the company reached a 52-week high of $17.30 on 03/06/24 and a 52-week low of $7.68 on 07/03/24. A 50-day SMA is recorded $9.80, while a 200-day SMA reached $11.30. Nevertheless, trading volume fell to 0.18 million shares from 0.37 million shares the previous day.
Support And Resistance Levels for Rigel Pharmaceuticals (RIGL)
According to the 24-hour chart, there is a support level at 7.46, which, if violated, would cause prices to drop to 7.19. In the upper region, resistance lies at 8.22. The next price resistance is at 8.71. RSI (Relative Strength Index) is 36.89 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.73, which suggests the price will decrease in the coming days. Percent R is at 98.44%, indicating bearish price movement. Stochastics%K at buying indicates that the stock is to be held.
